Mounjaro - European Public Assessment Report (EPAR)
As it turns out
The latest on the scene: retatrutide , a so-called "triple-agonist" that targets GLP-1, GIP, and glucagon receptors
This slower digestion means that people often feel satisfied for longer, reducing the urge to snack or overeat throughout the day
Working with your changing appetite GLP-1 receptor agonists reduce hunger by slowing gastric emptying, increasing satiety signals, and dampening the brains reward signals for heavy foods
The Bacterial Contamination Theory proposes that such dysbiosis introduces lipopolysaccharides (LPS) into the uterine environment, which activate pattern recognition receptors through binding to the TLR4/MD2 complex, triggering MyD88-dependent signaling that phosphorylates IB and liberates NF-B for nuclear translocation, ultimately inducing chronic inflammatory cascades and further exacerbating endometriotic pathology